All Mahima Datla articles

News

IVI starts technology transfer to Biological E. Limited to manufacture oral cholera vaccine for India and global markets

2024-03-20T11:17:00Z

The International Vaccine Institute (IVI) has announced that it has commenced a technology transfer of simplified Oral Cholera Vaccine (OCV-S) to Biological E. Limited (BE), a leading India-based vaccines and pharmaceutical company.